Elizabeth Whalley Buono, R.N., J.D., joined the MCV Foundation board in 2013.
Liz provides life sciences, fraud and abuse, healthcare innovation and new product development legal and regulatory support to a broad array of healthcare clients as a director at Hancock Daniel.
Liz began her legal career in 2001 at Wiley, Rein and Fielding LLP in Washington, D.C. where she supported consumer product, pharmaceutical, biotech and device firms on a wide range of federal and state regulatory issues. Prior to practicing law, she had careers as a medical/surgical and psychiatric nurse in the Boston area and had an extensive 13-year tenure in the pharmaceutical industry with Parke-Davis/Warner Lambert and Pfizer. In 2003, Liz joined Altria Client Services as regulatory and senior counsel, managing the legal and health ethics considerations associated with clinical research and new product development activities undertaken in pursuit of tobacco harm reduction. In 2009, Liz moved to WestRock/MWV Healthcare as V.P. for global quality, regulatory and external affairs and general counsel for the company’s healthcare division, with primary responsibility for ensuring compliance and creating competitive advantage for the company’s patient medication adherence products and services.
More recently, through her private consultancy, Liz supported healthcare innovation efforts undertaken by, among others, the Bill and Melinda Gates Foundation. She currently serves on the FDA Working Group to Enhance Opioid Safety and the CDC PROTECT Initiative.
Liz received her B.S.N. from Boston College School of Nursing and earned her M.B.A. in executive management from St. John’s University College of Business Administration. She received her J.D. in health law and economics from George Mason University.